Fumi Gomi, Tomohiro Iida, Ryusaburo Mori, Shinya Horita, Hiroaki Nakamura, Yu Nakajima, Ayako Shiokawa, Kanji Takahashi. Phase I Study of Tivozanib Eye Drops in Healthy Volunteers and Patients with Neovascular Age-Related Macular Degeneration. Ophthalmology Science. 2024. 4. 6. 100553-100553
Ruri Sugiyama, Ryusaburo Mori, Akiyuki Kawamura, Koji Tanaka, Hajime Onoe, Yu Wakatsuki, Hiroyuki Nakashizuka. The Evaluation of Change in Choroidal Circulation Time before and after Half-Dose Photodynamic Therapy in Central Serous Chorioretinopathy Using Wide-Field Indocyanine Green Angiography. Journal of Clinical Medicine. 2024. 13. 14. 4257-4257
Ryo Mukai, Keiko Kataoka, Koji Tanaka, Yasunori Miyara, Ichiro Maruko, Makiko Nakayama, Yuto Watanabe, Akiko Yamamoto, Yu Wakatsuki, Hajime Onoe, et al. One-year outcomes and safety assessment of faricimab in treatment-naïve patients with neovascular age-related macular degeneration in Japan. Scientific Reports. 2024. 14. 1
Hideki Koizumi, Fumi Gomi, Akitaka Tsujikawa, Shigeru Honda, Ryusaburo Mori, Haruka Ochi, Keisuke Iwasaki, Annabelle Ayame Okada. Efficacy, durability, and safety of faricimab up to every 16 weeks in patients with neovascular age-related macular degeneration: 2-year results from the Japan subgroup of the phase III TENAYA trial. Graefe's Archive for Clinical and Experimental Ophthalmology. 2024. 262. 8. 2439-2448
Hajime Onoe, Koji Tanaka, Norihiro Tsuchiya, Keisuke Miyata, Mai Kitaoka, Mao Nakayama, Ryusaburo Mori, Hiroyuki Nakashizuka. Maximum carotid intima-media thickness and NT-pro BNP in association with retinal vein occlusion. PLOS ONE. 2023. 18. 12. e0291456-e0291456
